Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Inside the Lab Clinical care, Hematology, Cytology, Histology, Laboratory management, Biochemistry and molecular biology, Precision medicine, Point of care testing, Screening and monitoring, Genetics and epigenetics, Technology and innovation, Omics

Biochip Breakthrough

At a Glance

  • A new portable biochip boasts the ability to detect microbes simultaneously and rapidly in clinical samples
  • The technology should allow doctors to identify drug-resistant strains and select the most effective treatments
  • Its creators hope that the technique will help with the fight against antimicrobial resistance by avoiding inappropriate antibiotic use
  • With the development of an open-source version of the platform, clinicians will be able to create custom chips that “scan” for new microbes as they are discovered

Antimicrobial resistance represents an increasingly serious threat to public health around the globe. Molecular diagnostics systems enable rapid identification of pathogens through nucleic acid amplification tests (NAATs) and occasionally facilitate the detection of resistance-causing mutations. But despite the promise of enabling appropriate antibiotic selection, existing systems are restricted by their limited multiplexing (the maximum number of strains and sequences that can be detected) and low accuracy for identifying point mutations, such as single nucleotide polymorphisms (SNPs). Now, a team of researchers has developed a new approach: a miniaturized semiconductor biochip and multiplexed NAAT that is capable of swiftly amplifying, detecting, and quantifying DNA or RNA sequences in their hundreds.

Read the full article now

Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE!

Login

Or register now - it’s free!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

When you click “Register” we will email you a link, which you must click to verify the email address above and activate your account. If you do not receive this email, please contact us at [email protected].

About the Authors

Luke Turner

While completing my undergraduate degree in Biology, I soon discovered that my passion and strength was for writing about science rather than working in the lab. My master’s degree in Science Communication allowed me to develop my science writing skills and I was lucky enough to come to Texere Publishing straight from University. Here I am given the opportunity to write about cutting edge research and engage with leading scientists, while also being part of a fantastic team!


Arjang Hassibi

The President, Chief Executive Officer, and a board member of InSilixa, which he founded in 2012 to commercialize the proprietary CMOS biosensor technologies that he had been developing in academia for almost a decade.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register